GlaxoSmithKline PLC (NYSE:GSK)
| 37.09 Delayed Data As of 4:00pm ET |  +0.35 / +0.95%Today’s Change | 31.43 Today|||52-Week Range 48.25 | -21.07% Year-to-Date |
Latest GSK News | Press Releases
Today’s Trading
| Previous close | 36.74 |
| Today’s open | 36.77 |
| Day’s range | 36.73 - 37.21 |
| Volume | 4,959,234 |
| Average volume (3 months) | 4,005,678 |
| Market cap | $92.8B |
Data as of 4:00pm ET, 11/24/2020
Growth & Valuation
| Earnings growth (last year) | +21.84% |
| Earnings growth (this year) | -5.69% |
| Earnings growth (next 5 years) | +3.33% |
| Revenue growth (last year) | +4.78% |
| P/E ratio | 11.0 |
| Price/Sales | 2.74 |
| Price/Book | 6.07 |
Competitors
Data as of 4:00pm ET, 11/24/2020
Financials
| Next reporting date | February 3, 2021 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $43.1B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 13.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
